Matthias Artaker
Impact in
-
- Cancer Cells and Metastasis
-
- Hemoglobinopathies and Related Disorders
Papers in
-
- Histone Deacetylase Inhibitors Research 3
- Epigenetics and DNA Methylation 3
- Protein Degradation and Inhibitors 2
- Wnt/β-catenin signaling in development and cancer 1
- Oncology 4
- Cancer Cells and Metastasis 2
- Cytokine Signaling Pathways and Interactions 1
- Co-authors
- Richard Moriggl (3 shared papers)Harini Nivarthi (2 shared papers)Albin Rudisch (2 shared papers)Martin Scherzer (2 shared papers)Wolfgang Sommergruber (2 shared papers)Helmut Dolznig (2 shared papers)Christine Unger (2 shared papers)Markus Hengstschläger (2 shared papers)
- Journals
- The EMBO Journal (2 papers)Oncogene (2 papers)Molecular Pharmacology (1 paper)Development (1 paper)Blood (1 paper)
- Partner nations
- AustriaPakistanUnited Kingdom
In The Last Decade
Matthias Artaker
7 papers receiving 411 citations
Peers
Comparison fields: 5 of 62
- Oncology 148
- Genetics 54
- Cancer Research 70
- Hematology 51
- Molecular Biology 259
Countries citing papers authored by Matthias Artaker
This map shows the geographic impact of Matthias Artaker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthias Artaker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthias Artaker more than expected).
Fields of papers citing papers by Matthias Artaker
This network shows the impact of papers produced by Matthias Artaker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthias Artaker. The network helps show where Matthias Artaker may publish in the future.
Co-authors
The 25 scholars most cited alongside Matthias Artaker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 105 | |
| 2 | 2014 | 96 | |
| 3 | 2008 | 81 | |
| 4 | 2014 | 70 | |
| 5 | 2010 | 34 | |
| 6 | 2013 | 28 | |
| 7 | 2011 | 2 |
About Matthias Artaker
Matthias Artaker is a scholar working on Molecular Biology, Oncology, Cancer Research, Physiology and Endocrinology, Diabetes and Metabolism, having authored 7 papers that have together received 416 indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (3 papers), Epigenetics and DNA Methylation (3 papers), Protein Degradation and Inhibitors (2 papers), Cancer Cells and Metastasis (2 papers), MicroRNA in disease regulation (1 paper), Cytokine Signaling Pathways and Interactions (1 paper), Cancer, Hypoxia, and Metabolism (1 paper) and Wnt/β-catenin signaling in development and cancer (1 paper). The work is most often cited by research in Oncology (148 citations), Genetics (54 citations), Cancer Research (70 citations), Hematology (51 citations) and Molecular Biology (259 citations). Matthias Artaker has collaborated with scholars based in Austria, Pakistan and United Kingdom. Frequent co-authors include Richard Moriggl, Harini Nivarthi, Albin Rudisch, Martin Scherzer, Wolfgang Sommergruber, Helmut Dolznig, Christine Unger, Markus Hengstschläger, Boris Kovačic and Oliver Pusch. Their work appears in journals such as The EMBO Journal, Oncogene, Molecular Pharmacology, Development and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.